Petra van der Groep

5.8k citations

67 papers · 3.7k indexed · 1 hit paper · h-index 33

Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 28
Oncology top 2%
- Cancer-related Molecular Pathways 12
- HER2/EGFR in Cancer Research 8
- Cancer Cells and Metastasis 6
Molecular Biology top 5%
- RNA modifications and cancer 6
- Fibroblast Growth Factor Research 5
Genetics top 5%
- BRCA gene mutations in cancer 11
- High Altitude and Hypoxia 6
Radiology, Nuclear Medicine and Imaging top 5%

Co-authors: P. J. van Diest Elsken van der Wall Reinhard Bos Gregg L. Semenza Avi Shvarts Astrid E. Greijer Paul J. van Diest Herbert M. Pinedo
Cited by: Cancer Research Oncology Molecular Biology
Journals: Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)Nature Communications (1 paper)
Partner nations: Netherlands United States Germany

In The Last Decade

Petra van der Groep

66 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Petra van der Groep

Since Specialization

Citations

This map shows the geographic impact of Petra van der Groep's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra van der Groep with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra van der Groep more than expected).

Fields of papers citing papers by Petra van der Groep

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra van der Groep. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra van der Groep. The network helps show where Petra van der Groep may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Petra van der Groep, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Petra van der Groep Line = papers co-authored together Petra van der Groep links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Modelling the impact of bias in fecal immunochemical testing on long-term outcomes of colorectal cancer screening Clinica Chimica Acta ·Lucie de Jonge,Esther Toes‐Zoutendijk,Brechtje D.M. Koopmann,Marith van Schrojenstein Lantman,Brenda Franken-van Vorsselen,Christel Speijers,Huub van Ingen,Erwin Humer,Petra van der Groep,Marc Thelen,Iris Lansdorp‐Vogelaar	2024	1
2	Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer Nature Communications ·Tesa Severson,Yongsoo Kim,Stacey E. P. Joosten,Karianne Schuurman,Petra van der Groep,Cathy B. Moelans,Natalie D. ter Hoeve,Quirine F. Manson,John W.M. Martens,Carolien H. M. van Deurzen,Ellis Barbé,Ingrid Hedenfalk,Peter Bult,Vincent T.H.B.M. Smit,Sabine C. Linn,P. J. van Diest,Lodewyk F.A. Wessels,Wilbert Zwart	2018	51
3	p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice Journal of Mammary Gland Biology and Neoplasia ·Milou Tenhagen,Sjoerd Klarenbeek,Tanya M. Braumuller,Ilse Hofmann,Petra van der Groep,Natalie D. ter Hoeve,Elsken van der Wall,Jos Jonkers,Patrick W.B. Derksen	2016	12
4	miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers Oncotarget ·Shoko Vos,Farhad Vesuna,Venu Raman,P. J. van Diest,Petra van der Groep	2015	22
5	Loss of p120-Catenin Induces Metastatic Progression of Breast Cancer by Inducing Anoikis Resistance and Augmenting Growth Factor Receptor Signaling Cancer Research ·Ron C.J. Schackmann,Sjoerd Klarenbeek,Eva J. Vlug,Suzan Stelloo,Miranda van Amersfoort,Milou Tenhagen,Tanya M. Braumuller,Jeroen F. Vermeulen,Petra van der Groep,Ton Peeters,Elsken van der Wall,P. J. van Diest,Jos Jonkers,Patrick W.B. Derksen	2013	48
6	Expression of the RNA Helicase DDX3 and the Hypoxia Response in Breast Cancer PLoS ONE ·Guus M. Bol,Venu Raman,Petra van der Groep,Jeroen F. Vermeulen,Arvind H. Patel,Elsken van der Wall,Paul J. van Diest	2013	50
7	Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient Annals of Oncology ·Laurien D.C. Hoefnagel,Petra van der Groep,Marc J. van de Vijver,James E. Boers,Pieter Wesseling,Jelle Wesseling,Elsken van der Wall,P. J. van Diest	2013	41
8	Expression of hypoxia-inducible factor-1α and -2α in whole-mount prostate histology: Relation with dynamic contrast-enhanced MRI and Gleason score Oncology Reports ·A. Borren,Greetje Groenendaal,Petra van der Groep,Maaike R. Moman,Arto E. Boeken Kruger,Uulke A. van der Heide,Trudy N. Jonges,P. J. van Diest,Marco van Vulpen,M.E.P. Philippens	2013	8
9	Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes Cancer Letters ·Cathy B. Moelans,Petra van der Groep,Laurien D.C. Hoefnagel,Marc J. van de Vijver,Pieter Wesseling,Jelle Wesseling,Elsken van der Wall,P. J. van Diest	2013	30
10	Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors Epigenetics ·Madeleine S.Q. Kortenhorst,Michel D. Wissing,Ronald Rodríguez,Sushant K. Kachhap,Judith Jans,Petra van der Groep,Henk M.W. Verheul,Anuj Gupta,Paul Aiyetan,Elsken van der Wall,Michael A. Carducci,P. J. van Diest,Luigi Marchionni	2013	30
11	Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets Endocrine Related Cancer ·Milou Tenhagen,P. J. van Diest,Iordanka A. Ivanova,Elsken van der Wall,Petra van der Groep	2012	44
12	Is there ‘progression through grade’ in ductal invasive breast cancer? Breast Cancer Research and Treatment ·Barbara Schymik,Horst Buerger,Annika Krämer,Ulli Voss,Petra van der Groep,Wolfgang Meinerz,P. J. van Diest,Eberhard Korsching	2012	15
13	HIF-1α and NOTCH signaling in ductal and lobular carcinomas of the breast Cellular Oncology ·Cigdem Ercan,Jeroen F. Vermeulen,Laurien D. Hoefnagel,Peter Bult,Petra van der Groep,Elsken van der Wall,P. J. van Diest	2012	11
14	Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance Journal of Clinical Investigation ·Ron C.J. Schackmann,Miranda van Amersfoort,Judith H.I. Haarhuis,Eva J. Vlug,Vincentius A. Halim,Jeanine M.L. Roodhart,Joost S.P. Vermaat,Emile E. Voest,Petra van der Groep,P. J. van Diest,Jos Jonkers,Patrick W.B. Derksen	2011	107
15	Pathology of hereditary breast cancer PubMed ·Petra van der Groep,Elsken van der Wall,Paul J. van Diest	2011	114
16	Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression Cellular Oncology ·A. Hyseni,Petra van der Groep,Elsken van der Wall,P. J. van Diest	2011	19
17	Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α Oncogene ·Farhad Vesuna,Ala Lisok,J. Brian Kimble,John Domek,Yoshinori Katō,Petra van der Groep,Dmitri Artemov,Jeanne Kowalski,Hetty E. Carraway,Paul van Diest,Venu Raman	2011	133
18	Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer PubMed ·Marise R. Heerma van Voss,Petra van der Groep,Joost Bart,Elsken van der Wall,P. J. van Diest	2011	27
19	The Peptidyl-Isomerase Pin1 Regulates p27kip1 Expression through Inhibition of Forkhead Box O Tumor Suppressors Cancer Research ·Arjan B. Brenkman,Peter L.J. de Keizer,Niels J. F. van den Broek,Petra van der Groep,P. J. van Diest,Armando van der Horst,Alida M.M. Smits,Boudewijn Burgering	2008	59
20	VEGF-D and HIF-1α in breast cancer Journal of Clinical Pathology ·P. J. van Diest,M M Vleugel,Petra van der Groep,Elsken van der Wall	2005	1

About Petra van der Groep

Petra van der Groep is a scholar working on Cancer Research, Oncology and Genetics, having authored 67 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (28 papers), Cancer-related Molecular Pathways (12 papers), BRCA gene mutations in cancer (11 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Cells and Metastasis (6 papers), RNA modifications and cancer (6 papers), High Altitude and Hypoxia (6 papers) and Fibroblast Growth Factor Research (5 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (1.2k citations) and Molecular Biology (1.9k citations). Petra van der Groep has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include P. J. van Diest, Elsken van der Wall, Reinhard Bos, Gregg L. Semenza, Avi Shvarts, Astrid E. Greijer, Paul J. van Diest, Herbert M. Pinedo, Sybren Meijer and Анна Шварц. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact